AMVUTTRA vs ONPATTRO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. AMVUTTRA and ONPATTRO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AMVUTTRA	ONPATTRO
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	VUTRISIRAN SODIUM	PATISIRAN SODIUM
Manufacturer	Alnylam Pharms Inc	Alnylam Pharms Inc
Dosage forms	Injectable	Injectable, Lipid complex
Drug class	Small Interfering Rna	Small Interfering Rna
Boxed warning	None	None
Treats	Polyneuropathies, Familial Amyloid Neuropathies	Familial Amyloid Neuropathies

amvuttra onpattro

Rating

New

Pharmacy pays

—

Type

Active ingredient

VUTRISIRAN SODIUM

PATISIRAN SODIUM

Manufacturer

Alnylam Pharms Inc

Dosage forms

Injectable

Injectable, Lipid complex

Drug class

Small Interfering Rna

Boxed warning

None

Treats

Polyneuropathies, Familial Amyloid Neuropathies

Familial Amyloid Neuropathies

Frequently asked questions

What is the difference between Amvuttra and Onpattro?

Amvuttra contains Vutrisiran Sodium, while Onpattro contains Patisiran Sodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.